glp 1 interactions with other drugs Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition GLP-1 Medications: Everything You Need

Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

But patients are at the heart of the GLP-1 trend, and the []

Please note: The Microdosing Program is offered only at a fixed, low starting dose and does not increase over time

Discover how the GLP-1 revolution with Ozempic and Mounjaro is transforming Type 2 diabetes and obesity treatment, offering new hope and solutions.

Ongoing check-ins and nurse access keep you on track